Skip to content

Clinical trials

Breast Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Diseases Country / region: China Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20131
20151
20182
20194
20202
20213
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status9
Recruiting5
Completed3
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ma Zhe3
AstraZeneca2
Binghe Xu1
Ensem Therapeutics1
FangYi1
Fujian Cancer Hospital1
Fuzhou General Hospital1
Haiyan Li1
Huazhong University of Science and Technology1
Peking Union Medical College Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Diseases20
Breast Neoplasms12
Neoplasm Metastasis3
Neoplasms3
Neoplasms by Site3
Skin Diseases2
Anemia1
Constipation1
Disease1
Endometrial Neoplasms1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.